CN103784942B - 青蒿琥酯与乌司他丁联合治疗胰腺炎的用途 - Google Patents
青蒿琥酯与乌司他丁联合治疗胰腺炎的用途 Download PDFInfo
- Publication number
- CN103784942B CN103784942B CN201410058044.XA CN201410058044A CN103784942B CN 103784942 B CN103784942 B CN 103784942B CN 201410058044 A CN201410058044 A CN 201410058044A CN 103784942 B CN103784942 B CN 103784942B
- Authority
- CN
- China
- Prior art keywords
- ulinastatin
- artesunate
- acute pancreatitis
- associating
- pancreatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410058044.XA CN103784942B (zh) | 2014-02-20 | 2014-02-20 | 青蒿琥酯与乌司他丁联合治疗胰腺炎的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410058044.XA CN103784942B (zh) | 2014-02-20 | 2014-02-20 | 青蒿琥酯与乌司他丁联合治疗胰腺炎的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103784942A CN103784942A (zh) | 2014-05-14 |
CN103784942B true CN103784942B (zh) | 2015-03-04 |
Family
ID=50661277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410058044.XA Expired - Fee Related CN103784942B (zh) | 2014-02-20 | 2014-02-20 | 青蒿琥酯与乌司他丁联合治疗胰腺炎的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103784942B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906558B (zh) * | 2015-07-08 | 2016-11-16 | 广东天普生化医药股份有限公司 | 治疗宫颈癌的含有乌司他丁的药物组合物 |
CN111362964B (zh) * | 2020-03-19 | 2022-03-08 | 中国人民解放军陆军军医大学 | 青蒿琥酯的琥珀酯化衍生物及其制备方法和药物中的用途 |
CN112546043A (zh) * | 2020-12-15 | 2021-03-26 | 烟台拉斐尔生物科技有限公司 | 一种二氢欧山芹醇的应用及治疗急性胰腺炎的药物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1561994A (zh) * | 2004-04-02 | 2005-01-12 | 齐岩 | 治疗类风湿性关节炎和免疫性疾病的含青蒿提取物药物组合物 |
WO2007125397A2 (en) * | 2006-04-27 | 2007-11-08 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acidity using endoperoxide bridge-containing compounds |
-
2014
- 2014-02-20 CN CN201410058044.XA patent/CN103784942B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103784942A (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103989713B (zh) | 免疫增强组成物及其制造方法 | |
JP6473505B2 (ja) | 局所の脂肪と体重の減少に用いられる組成物およびその医薬品と使用 | |
CN103784942B (zh) | 青蒿琥酯与乌司他丁联合治疗胰腺炎的用途 | |
KR101117861B1 (ko) | 포르시토사이드 주사제와 그 제조 방법 | |
KR20160070152A (ko) | 혈구 감소를 예방 또는 치료하기 위한 약물의 제조에 있어서의 이카리틴의 용도 | |
CN101972471A (zh) | 乌司他丁用于制备治疗自身免疫性脑脊髓炎药物的用途及其药物组合物 | |
CN116590200A (zh) | 约氏乳杆菌及其在制备预防和/或改善急性胰腺炎的产品中的应用 | |
Ossendorff et al. | Methods of Conservative Intra-Articular Treatment for Osteoarthritis of the Hip and Knee | |
CN113493491B (zh) | 一种用于预防或治疗溃疡性结肠炎的多肽 | |
CN101301465A (zh) | 禽转移因子纳米脂质体及其制备方法 | |
JP2009538838A (ja) | 予防或いは肝損傷を治療するペプチッド | |
CN107998116B (zh) | 乙酰胺在抗银屑病药物中的应用 | |
CN102895264A (zh) | 红色诺卡氏菌细胞壁骨架口含片及其制备方法 | |
CN102716179A (zh) | 预防或者治疗纤维化疾病的中药组合物及制备方法和用途 | |
CN107308121A (zh) | 肝脏再生的治疗剂 | |
KR101266527B1 (ko) | 동충하초 균사체 추출물을 유효성분으로 함유하는 면역 억제용 조성물 | |
US20130195797A1 (en) | High potency formulations of vx-950 | |
CN101376022B (zh) | 含聚乙二醇降纤酶的药物组合物 | |
CN101686992B (zh) | 卡介菌多糖核酸提取物在制备治疗变态反应性皮肤病的药物中的应用及其注射剂和制备方法 | |
CN110368429A (zh) | 防治细菌性肠胃炎拉痢的中药组合物及其制备方法 | |
CN104605344A (zh) | 一种增强免疫力的保健食品及其制备方法 | |
TW202002996A (zh) | 含肽調配物 | |
Colombani et al. | Harnessing the Potential of Biomaterials for COVID-19 Therapeutic Strategies | |
CN106983716A (zh) | 重组人干扰素α2a栓及制备方法 | |
CN109806271B (zh) | 一种治疗过敏性皮炎的药物组合物及其制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20140514 Assignee: Chongqing Shenghuaxi Pharmaceutical Co., Ltd. Assignor: Third Military Medical University, Chinese People's Liberation Army Contract record no.: 2016500000010 Denomination of invention: Application of artesunate and ulinastatin in combined treatment of pancreatitis Granted publication date: 20150304 License type: Exclusive License Record date: 20160520 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150304 Termination date: 20200220 |
|
CF01 | Termination of patent right due to non-payment of annual fee |